EUXS:LSE:LSE-iShares MSCI Europe Ex UK GBP (GBX)

ETF | Others |

Last Closing

USD 789.45

Change

+1.70 (+0.22)%

Market Cap

USD 0.15B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+6.50 (+3.14%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.17 (-1.15%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.12 (-0.65%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+7.95 (+6.53%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
PRJU:LSE Amundi Index Solutions - Amund..

-0.23 (-0.72%)

USD 269.13B
0QZK:LSE Coca-Cola Co.

-0.30 (-0.43%)

USD 266.08B
0QZO:LSE 0QZO

+1.10 (+1.00%)

USD 258.54B
0QZ3:LSE Qualcomm Inc.

-1.50 (-0.98%)

USD 202.26B
0R24:LSE Intel Corp.

+0.71 (+3.22%)

USD 196.14B

ETFs Containing EUXS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.78% 79% B- 75% C
Dividend Return 0.01% 22% F 14% F
Total Return 9.78% 79% B- 74% C
Trailing 12 Months  
Capital Gain 5.22% 52% F 58% F
Dividend Return 0.02% 17% F 13% F
Total Return 5.24% 48% F 55% F
Trailing 5 Years  
Capital Gain 78.17% 65% D 71% C-
Dividend Return 0.15% 19% F 26% F
Total Return 78.32% 61% D- 69% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.13% 63% D 67% D+
Dividend Return 9.13% 62% D 66% D+
Total Return 0.00% 2% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 12.64% 51% F 70% C-
Risk Adjusted Return 72.20% 72% C 82% B
Market Capitalization 0.15B 56% F 32% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.